Fact CheckerSign in

NCT07166588Enrolling by invitation

Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
2000 (estimated)
First submitted
3 Sept 2025
Start date
20 Jan 2021
Primary completion date
31 Dec 2026
Lead sponsor
Seoul National University Hospital
NCT number
NCT07166588

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 20 Jan 2021 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients diagnosed with cancer or with a history of cancer treatment.

Age

  • Infants and young children under the age of 10.

Other

  • Participation may be restricted at the discretion of the medical team.

Who the study is looking for

  • Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.

Age in the registry: 10 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.